JPMorgan Chase & Co. downgraded Change Healthcare from Overweight to Neutral
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
9/20/2022 | $26.00 → $27.75 | Overweight → Neutral | Piper Sandler |
9/20/2022 | $27.75 | Buy → Neutral | Citigroup |
9/7/2022 | $27.75 | Hold | Truist |
4/1/2022 | $25.75 | Neutral | Credit Suisse |
2/4/2022 | $25.75 | Neutral → Buy | Citigroup |
Piper Sandler downgraded Change Healthcare from Overweight to Neutral and set a new price target of $27.75 from $26.00 previously
Citigroup downgraded Change Healthcare from Buy to Neutral and set a new price target of $27.75
Truist initiated coverage of Change Healthcare with a rating of Hold and set a new price target of $27.75
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)